1. Introduction {#sec1-pharmaceuticals-09-00007}
===============

Plants are important sources for the preparation of natural remedies, food additives, and other ingredients, as they contain many biologically active compounds as polyphenols, vitamins (A, B group, C, E), terpenes, organic acids, and other very important phytochemicals \[[@B1-pharmaceuticals-09-00007],[@B2-pharmaceuticals-09-00007]\]. For this reason, plant material and herbal preparations have been widely used for hundreds of years all over the world \[[@B3-pharmaceuticals-09-00007]\]: they have provided a complete storehouse of remedies to cure acute and chronic diseases. Berry species have been demonstrated to exhibit a broad spectrum of benefits; in particular, blackberry (*Rubus* cultivated varieties) sprouts and blackcurrant (*Ribes nigrum* L.) buds are known to contain appreciable levels of vitamins, terpenic and phenolic compounds, including flavonols, phenolic acids and catechins \[[@B4-pharmaceuticals-09-00007],[@B5-pharmaceuticals-09-00007]\]. The most important industrial product of blackcurrant is its fruits, however, the leaves and buds, due to their characteristic chemical composition and excellent flavor, have also found some applications as a raw material for the herbal and cosmetic industries. Many people use its buds as a medicinal preparation for its anti-inflammatory activity and against dermal diseases (eczema and psoriasis) \[[@B6-pharmaceuticals-09-00007],[@B7-pharmaceuticals-09-00007]\]. On the other hand, blackberry sprouts have been used in traditional medicine for their medicinal antioxidant, anti-haemorrhoidal and anti-diarrhoeal activity properties \[[@B8-pharmaceuticals-09-00007],[@B9-pharmaceuticals-09-00007]\].

Phytotherapy is the study of natural extracts used as health-promoting products for medical care \[[@B10-pharmaceuticals-09-00007]\]. The idea comes from the observation that certain plants, or parts thereof, taken as food, may have therapeutic effects. Every early civilization has used plants or parts of plants (buds, leaves, sprouts, flowers, fruits, seeds, bark, roots) as their main source of healthcare, and this holds true even today in many rural populations \[[@B11-pharmaceuticals-09-00007]\]. Moreover, there is also a greater tendency toward regular use of alternative therapies in the main European countries: 49% and 46% of the population in France and Germany, respectively, use them regularly, along with 35%, 31%, and 25% of the population in the United Kingdom, Belgium, and the Northern Europe countries, respectively \[[@B12-pharmaceuticals-09-00007]\]. Natural medicine has not been officially recognized in most countries \[[@B13-pharmaceuticals-09-00007]\], but increasing acceptance by consumers and medical professionals has pushed world demand for herbal extracts up 7.5% annually to US \$1.95 billion in 2012 \[[@B14-pharmaceuticals-09-00007],[@B15-pharmaceuticals-09-00007]\].

Gemmotherapy is the most recent of therapeutic techniques developed on the basis of the plant medical properties. It uses the properties of extracts obtained by the maceration in ethanol and glycerol of fresh meristematic plant tissues, mainly buds and sprouts, for medicinal purposes. The products are commercially known as bud-preparations. In herbal preparations, due to the large quantity of bioactive compounds, many of which act synergistically, there is a preference to attribute the pharmacological effect to the "phytocomplex" (a combination of different substances, both active principles and other plant components), rather than to any single active compound, as in the case of standard medicine \[[@B16-pharmaceuticals-09-00007]\].

In recent years phytotherapy has become a fully fledged medical discipline, as the knowledge gleaned from folk medicine has since been subjected to methodical scientific assessments in order to provide evidence of its efficacy \[[@B17-pharmaceuticals-09-00007]\]. However, the fast growth of the herbal products industry and the lack of corresponding regulations and legislations have caused the World Health Organization (WHO) and other regulatory bodies to be increasingly concerned with the safety and efficacy of herbal medicines \[[@B18-pharmaceuticals-09-00007],[@B19-pharmaceuticals-09-00007]\]. In particular, research on bud-preparations, until now, has been only focused on their clinical effects and research on raw material origins, cultivation and quality is still lacking \[[@B20-pharmaceuticals-09-00007]\]. Instead, quality control of natural products is extremely important, as the effectiveness and quality of herbal medicines depend on the concentrations of their active ingredients \[[@B21-pharmaceuticals-09-00007]\]. Key factors that can affect the quality and quantity of these compounds include the plant genotype, pedoclimatic conditions, applied agronomic techniques and phenological stage in which the buds are harvested \[[@B22-pharmaceuticals-09-00007],[@B23-pharmaceuticals-09-00007]\]. Moreover, the herbal preparation quality is also determined by the subsequent processing and storage procedures \[[@B24-pharmaceuticals-09-00007]\].

The lack of information on the intrinsic and extrinsic factors that determine the quality and effectiveness of bud-preparations indicates the need to extend research on this topic, however, due to the variability and complexity of bud-preparations, it is very difficult to control their product quality \[[@B25-pharmaceuticals-09-00007]\]. The key factors in achieving this objective are the determination of chemical composition and the standardization of herbal preparations. The definition of a chromatographic (High Performance Liquid Chromatography---HPLC) fingerprint allows for the qualitative and quantitative evaluation of phytocomplex components \[[@B26-pharmaceuticals-09-00007],[@B27-pharmaceuticals-09-00007]\]. In particular, the best method of identifying preparations is by measuring the concentration of the main bioactive compounds, called "biomarkers" \[[@B28-pharmaceuticals-09-00007],[@B29-pharmaceuticals-09-00007]\].

Given the above, the aim of this research was to perform an analytical study of blackcurrant and blackberry bud-preparations using simple, sensitive and reliable HPLC--diode array detector (DAD) methods in order to identify and quantify the main phytochemicals (biomarkers) and to be able to obtain a specific botanical fingerprint for the assessment of the single bioactive class contribution to total bud preparation phytochemical profile The influence of genotype and harvest stage on these bioactive substances in the bud-extracts was also analysed. The same analyses were performed both on laboratory preparations and on commercial preparations.

2. Results and Discussion {#sec2-pharmaceuticals-09-00007}
=========================

Recently, many screening studies of different plant materials have been performed in order to find naturally occurring antioxidant compounds for use in food or medicinal preparations as replacements for potentially harmful synthetic additives \[[@B30-pharmaceuticals-09-00007]\]. Phenolic acids, flavonols and catechins were often selected for quantitative studies \[[@B31-pharmaceuticals-09-00007],[@B32-pharmaceuticals-09-00007]\]. In this case, the extracts of the analyzed species are recommended by physicians to be consumed as phytochemical supplements, and further information could be used to direct future research towards condition-specific beneficial properties associated with their therapeutic effects \[[@B33-pharmaceuticals-09-00007],[@B34-pharmaceuticals-09-00007]\].

The chemical composition of secondary plant metabolites is highly dependent on several factors such as climatic conditions, harvesting time, and plant genotype \[[@B35-pharmaceuticals-09-00007],[@B36-pharmaceuticals-09-00007],[@B37-pharmaceuticals-09-00007]\]. The present study showed that bioactive compound concentration in bud-preparations can be properly defined and characterized on the basis of chemical, agricultural and environmental knowledge. Different genotypes presented different chemical composition, but it was also important to consider that the pedoclimatic conditions of sampling sites strongly influence the presence of these compounds, as comparing the results of commercial bud-preparations.

Blackcurrant bud-preparations have been identified as herbal products with a high health-value ([Figure 1](#pharmaceuticals-09-00007-f001){ref-type="fig"}). The second phenological stage (bud break) was the best for the blackcurrant bud harvesting because it presented the highest values of bioactive compounds, followed by the first step (bud sleeping) and the third one (first leaves). In all the phenological stages, Tenah cultivar showed a greater phytochemical content (1527.70 mg/100 g~FW~, bud break) than Rozenthal cultivar (1181.11 mg/100 g~FW~, bud break).

![Effect of bud phenological stage on the bioactive compound content (TBCC) in final blackcurrant bud-preparations. Different letters for each sample indicate the significant differences at *p* \< 0.05.](pharmaceuticals-09-00007-g001){#pharmaceuticals-09-00007-f001}

The blackberry herbal preparations showed different chemical compositions with a high antioxidant compound content. Bud break was again the best phenological stage for bud harvesting, followed by the first step and third one ([Figure 2](#pharmaceuticals-09-00007-f002){ref-type="fig"}). Kiowa cultivar (1039.78 mg/100 g~FW~, bud break) and wild variety (1026.73 mg/100 g~FW~, bud break) presented a greater total bioactive compound content (TBCC) than Black Pearl cultivar (935.98 mg/100 g~FW~, bud break). As reported in similar studies \[[@B38-pharmaceuticals-09-00007]\], the analysis carried out on commercial bud-products highlighted significant statistical differences between species (RC1 *vs*. RRC1 and RC2 *vs.* RRC2), but there were no differences between companies (RC1 *vs*. RC2 and RRC1 *vs.* RRC2) ([Figure 3](#pharmaceuticals-09-00007-f003){ref-type="fig"}), confirming a production supply chain standardized according to the official Pharmacopoeia protocols.

![Effect of bud phenological stage on the bioactive compound content in blackberry final bud-preparations. Different letters for each sample indicate the significant differences at *p* \< 0.05.](pharmaceuticals-09-00007-g002){#pharmaceuticals-09-00007-f002}

![Total bioactive compound content in commercial bud-preparations. Different letters for each sample indicate the significant differences at *p* \< 0.05.](pharmaceuticals-09-00007-g003){#pharmaceuticals-09-00007-f003}

Bud-preparation phytochemical fingerprints of the selected genotypes are reported. In total, 26 botanicals were evaluated by HPLC/DAD. By single bioactive compound profile, phytochemicals were grouped into single bioactive classes to evaluate the contribution of each class to total phytocomplex composition \[[@B39-pharmaceuticals-09-00007]\]. Fingerprint profiles showed the prevalence of different bioactive classes in chemical composition of all the analyzed preparations depending on genotype. In [Figure 4](#pharmaceuticals-09-00007-f004){ref-type="fig"}, the *R. nigrum* bud-preparation phytocomplex (mean values were considered) showed the prevalence of organic acids (50.98%) and polyphenols (29.39%), followed by monoterpenes (14.04%) and vitamins (5.98%). In *Rubus* cultivated varieties bud-extracts phytocomplex ([Figure 5](#pharmaceuticals-09-00007-f005){ref-type="fig"}), the most important bioactive class was polyphenols (71.03%), followed by organic acids (27.34%) and vitamins (1.36%). Monoterpenes were not detected in blackberry preparations. Commercial preparations of the same species from different companies showed similar phytocomplexes, while the differences among species were confirmed according to the previous results obtained on lab preparations; moreover, the percentage ratio between bioactive class content (polyphenols, monoterpenes, organic acids and vitamins) and TBCC confirmed these results ([Figure 6](#pharmaceuticals-09-00007-f006){ref-type="fig"}).

![Contribution of each bioactive class to blackcurrant total phytocomplex. For the phytocomplex graphical representation, the second phenological stage was selected (bud break). Mean values of all the analyzed genotypes were considered.](pharmaceuticals-09-00007-g004){#pharmaceuticals-09-00007-f004}

![Contribution of each bioactive class to blackberry total phytocomplex. For the phytocomplex graphical representation, the second phenological stage was selected (bud break). Mean values of all the analyzed genotypes were considered.](pharmaceuticals-09-00007-g005){#pharmaceuticals-09-00007-f005}

![Contribution of each bioactive class to total phytocomplex in commercial bud-preparations.](pharmaceuticals-09-00007-g006){#pharmaceuticals-09-00007-f006}

The obtained fingerprints, and relative phytocomplexes, were useful for authentication and quality control purposes, as shown in other studies \[[@B40-pharmaceuticals-09-00007],[@B41-pharmaceuticals-09-00007]\]. Most of the research pointed out that the identified antioxidant compounds (polyphenols and vitamins) contribute significantly to the total phytocomplex of herbal preparations \[[@B31-pharmaceuticals-09-00007],[@B42-pharmaceuticals-09-00007]\]: the present study confirmed these results, adding as well as the terpenic and organic compounds also significantly contributed to the bud-preparation phytocomplex, as anti-inflammatory and volatile constituents in herbal preparations.

In this study, HPLC-DAD methods were used for fingerprint analysis and component identification of blackcurrant and blackberry bud-preparations. Comparing with other analytical studies \[[@B5-pharmaceuticals-09-00007],[@B43-pharmaceuticals-09-00007]\], the chromatographic conditions were optimized in order to obtain a fingerprint with good peak resolution and reasonable analysis time for the separation and quantification of different bioactive classes in plant material derived-products. These methods could be applied in routine quality control and standardization of bud-extracts, germplasm evaluation and selection of new cultivars with high content of biomolecules, and phytochemical fingerprinting of the plant material to be used in pharmaceutical investigations, in particular avoiding substitutions, changes or adulterations with other species or synthetic drugs (e.g., sildenafil, diazepam, captopril and amoxicillin), as shown in other studies \[[@B44-pharmaceuticals-09-00007],[@B45-pharmaceuticals-09-00007]\].

This study only focused on bud-preparation chemical composition of two berryfruit species, in order to detect and quantify the most important biologically active classes and single compounds, but a further quantitative evaluation on the basis of their native structures with Nuclear Magnetic Resonance (NMR) or HPLC coupled to mass spectrometry is necessary.

3. Materials and Methods {#sec3-pharmaceuticals-09-00007}
========================

3.1. Plant Material {#sec3dot1-pharmaceuticals-09-00007}
-------------------

University lab preparations and commercial preparations were evaluated. Samples of *Ribes nigrum* L. (buds) and *Rubus* cultivated varieties (sprouts) were collected in 2014, in three different phenological stages (bud sleeping, bud break, and first leaves), from two germplasm repositories in Turin Province (Italy), Grugliasco (*Rubus* cultivated varieties) and San Secondo di Pinerolo (*R. nigrum*). Different genotypes were sampled, in order to test the genotype effect on the final product chemical composition (blackcurrant: Rozenthal and Tenah; blackberry: Black Pearl, Kiowa and a wild variety). Buds and sprouts were used fresh to prepare herbal preparations; HPLC samples were analyzed after being stored for a few days at normal atmosphere (N.A.), at 4 °C and 95% relative humidity (R.H.). Commercial products from two different Italian herbal companies were also analyzed: the companies are located in San Gregorio di Catania (Catania Province, Company 1), and Predappio (Forlì-Cesena Province, Company 2). [Table 1](#pharmaceuticals-09-00007-t001){ref-type="table"} shows the genotypes, the sampling times and sites of analyzed herbal preparations (University and commercial preparations).

pharmaceuticals-09-00007-t001_Table 1

###### 

Genotype, sampling time, provenience and identification code of the analyzed bud-preparations.

  *University bud-preparations*                                                                                             
  ----------------------------------- -------------------------------- ---------- ----------------------------------------- -------------------------
  *Ribes nigrum* L.                   Rozenthal                        2014       San Secondo di Pinerolo, Torino, Italy    RR
  Tenah                               RT                                                                                    
  *Rubus ulmifolius* Schott           Black Pearl                      2014       Grugliasco, Torino, Italy                 RRBP
  Kiowa                               RRK                                                                                   
  Wild variety                        RRW                                                                                   
  ***Commercial bud-preparations***                                                                                         
  **Species**                         **Company**                      **Year**   **Germplasm repository**                  **Identification code**
  *Ribes nigrum* L.                   Company 1                        2013       San Gregorio di Catania, Catania, Italy   RC1
  Company 2                           Predappio, Forlì-Cesena, Italy   RC2                                                  
  *Rubus ulmifolius* Schott           Company 1                        2013       San Gregorio di Catania, Catania, Italy   RRC1
  Company 2                           Predappio, Forlì-Cesena, Italy   RRC2                                                 

3.2. Solvents and Chemicals {#sec3dot2-pharmaceuticals-09-00007}
---------------------------

Ethanol, hydrochloric acid, formic acid and all the organic acid standards were purchased from Fluka Biochemika (Buchs, Switzerland). Analytic HPLC grade acetonitrile, methanol, glycerol, all the polyphenolic and terpenic standards, potassium dihydrogen phosphate, 1,2-phenylenediamine dihydrochloride (OPDA) and phosphoric acid were purchased from Sigma Aldrich (Saint Louis, MO, USA). Milli-Q ultrapure water was produced by using a Sartorius Stedium Biotech mod. Arium apparatus (Sartorius, Goettingen, Germany). Cetyltrimethylammonium bromide (cetrimide), ascorbic and dehydroascorbic acids were purchased from Extrasynthése (Genay, France).

3.3. Sample Preparation Protocols {#sec3dot3-pharmaceuticals-09-00007}
---------------------------------

The extraction solution was prepared based on the protocol of bud-preparations detailed in the monograph "Homeopathic preparations", quoted in the French Pharmacopoeia, 8th edition, 1965 \[[@B46-pharmaceuticals-09-00007]\]. The bud mother solutions were prepared using one part of the fresh material (calculated as dried weight) in 20 parts of glycerol-ethanol solution (1:1 ratio). Bioactive molecules were extracted through a cold maceration process for 21 days, in a solution of ethanol (95%) and glycerol, followed by a first filtration (Whatman Filter Paper, Hardened Ashless Circles, 185 mm Ø), a manual pressing and, after two days of decanting, a second filtration (Whatman Filter Paper, Hardened Ashless Circles, 185 mm Ø). Macerated preparations were filtered with circular pre-injection filters (0.45 µm, polytetrafluoroethylene membrane, PTFE) and then stored for a few days at N.A., 4 °C and 95% R.H until analysis. All samples were analyzed as such without dilution. For vitamin C analysis, 250 µL of OPDA solution (18.8 mmol/L) was added to 750 µL of extracted samples for dehydroascorbic acid derivatization into the fluorophore 3-(1,2-dihydroxyethyl)-furo(3,4-b)quinoxalina-1-one (DFQ). After 37 min in the dark the samples were analyzed with a High Performance Liquid Chromatograph (HPLC) coupled to a diode array detector (DAD) \[[@B10-pharmaceuticals-09-00007]\].

3.4. Apparatus and Chromatographic Conditions {#sec3dot4-pharmaceuticals-09-00007}
---------------------------------------------

An Agilent 1200 High Performance Liquid Chromatograph, equipped with a G1311A quaternary pump, a manual injection valve, and a 20 μL sample loop, coupled to an Agilent GI315D UV-Vis diode array detector (Agilent Technologies, Santa Clara, CA, USA), was used for the analysis. Five different chromatographic methods were used to analyze the samples, two for polyphenols and one for monoterpenes, organic acids, and vitamins, respectively. In all of the used methods, bioactive compound separation was achieved on a KINETEX--C18 column (4.6 × 150 mm, 5 μm, Phenomenex, Torrance, CA, USA). Different mobile phases were used for a specific bioactive compound identification and UV spectra were recorded at 330 nm (A); 280 nm (B); 210, 220, 235, and 250 (C); 214 nm (D); 261, and 348 nm (E). The chromatographic conditions of each method were reported in [Table 2](#pharmaceuticals-09-00007-t002){ref-type="table"}.

3.5. Identification and Quantification of Bioactive Compounds {#sec3dot5-pharmaceuticals-09-00007}
-------------------------------------------------------------

All the single compounds were identified in samples by comparison and combination of their retention times and UV spectra with those of authentic standards in the same chromatographic conditions. The external standard method was used for quantitative determinations. Twenty μL aliquots of each standard solution were used for HPLC analysis and injections were performed in triplicate for each concentration level. For reference compounds, the limit of detection (LOD) and the limit of quantification (LOQ) were experimentally determined by HPLC analysis of serial dilutions of a standard solution to reach a signal-to-noise (S/N) ratio of 3 and 10, respectively. The main analytical method validation data are summarized in [Table 3](#pharmaceuticals-09-00007-t003){ref-type="table"}.

All samples were analyzed in triplicate, and standard deviations are given in order to assess the repeatability of the used methods. Accuracy was checked using the recovery test by spiking samples with a solution containing each bioactive compound (10 mg·mL^−1^) to reach 100% of the test concentration.

pharmaceuticals-09-00007-t002_Table 2

###### 

Chromatographic conditions of each used method \[[@B10-pharmaceuticals-09-00007]\].

  Method                           Compounds of interest       Stationary phase                         Mobile phase                                                Flow *(mL min^−1^)*   Time of analysis *(min)*   Gradient   Wavelenght *(nm)*
  -------------------------------- --------------------------- ---------------------------------------- ----------------------------------------------------------- --------------------- -------------------------- ---------- -------------------
  A                                cinnamic acids, flavonols   KINETEX--C18 column (4.6×150 mm, 5 μm)   A: 10 mM KH~2~PO~4~/H~3~PO~4~, pH=2.8;                      1.5                   20+2 (CT)                  Yes        330
  B: CH~3~CN                                                                                                                                                                                                                    
  B                                benzoic acids, catechins    KINETEX--C18 column (4.6×150 mm, 5 μm)   A: H~2~O/CH~3~OH/HCOOH (5:95:0.1 v/v/v), pH=2.5;            0.6                   23+2 (CT)                  Yes        280
  B: CH~3~OH/HCOOH (100:0.1 v/v)                                                                                                                                                                                                
  C                                monoterpenes                KINETEX--C18 column (4.6×150 mm, 5 μm)   A: H~2~O;                                                   1.0                   17+3 (CT)                  Yes        210, 220,
  B: CH~3~CN                       235, 250                                                                                                                                                                                     
  D                                organic acids               KINETEX--C18 column (4.6×150 mm, 5 μm)   A: 10 mM KH~2~PO~4~/H~3~PO~4~, pH=2.8;                      0.6                   13+2 (CT)                  No         214
  B: CH~3~CN                                                                                                                                                                                                                    
  E                                vitamins                    KINETEX--C18 column (4.6×150 mm, 5 μm)   A: 5 mM C~16~H~33~N(CH~3~)~3~Br/50 mM KH~2~PO~4~, pH=2.5;   0.9                   10+5 (CT)                  No         261, 348
  B: CH~3~OH                                                                                                                                                                                                                    

pharmaceuticals-09-00007-t003_Table 3

###### 

Identification standard codes, standard t~R~, calibration curve equations, *R^2^*, calibration curve ranges, LOD, and LOQ of the used chromatographic methods for each calibration standard \[[@B10-pharmaceuticals-09-00007]\].

  Class                  Standard        Identification code   Retention time (t~R~) (min)   Wavelenght (nm)   Method                 Calibration curve equation   *R^2^*      Calibration curve range (mg L^−1^)   LOD (mg L^−1^)   LOQ (mg L^−1^)
  ---------------------- --------------- --------------------- ----------------------------- ----------------- ---------------------- ---------------------------- ----------- ------------------------------------ ---------------- ----------------
  Cinnamic acids         caffeic acid    1                     4.54                          330               A                      y = 59.046x + 200.6          0.996       111--500                             0.305            1.016
  chlorogenic acid       2               3.89                  330                           A                 y = 13.583x + 760.05   0.984                        111--500    0.940                                3.134            
  coumaric acid          3               6.74                  330                           A                 y = 8.9342x + 217.4    0.997                        111--500    2.907                                9.690            
  ferulic acid           4               7.99                  330                           A                 y = 3.3963x − 4.9524   1.000                        111--500    1.245                                4.150            
  Flavonols              hyperoside      5                     10.89                         330               A                      y = 7.1322x − 4.583          0.999       111--500                             3.372            11.241
  isoquercitrin          6               11.24                 330                           A                 y = 8.3078x + 26.621   0.999                        111--500    0.252                                0.840            
  quercetin              7               17.67                 330                           A                 y = 3.4095x − 98.307   0.998                        111--500    4.055                                13.518           
  quercitrin             8               13.28                 330                           A                 y = 2.7413x + 5.6367   0.998                        111--500    5.456                                18.187           
  rutin                  9               12.95                 330                           A                 y = 6.5808x + 30.831   0.999                        111--500    2.937                                9.790            
  Benzoic acids          ellagic acid    10                    18.65                         280               B                      y = 29.954x + 184.52         0.998       62.5--250                            0.611            2.035
  gallic acid            11              4.26                  280                           B                 y = 44.996x + 261.86   0.999                        62.5--250   0.435                                1.451            
  Catechins              catechin        12                    10.31                         280               B                      y = 8.9197x + 66.952         1.000       62.5--250                            2.343            7.809
  epicatechin            13              14.30                 280                           B                 y = 12.88x − 43.816    0.999                        62.5--250   0.763                                2.543            
  Monoterpenes           limonene        14                    3.35                          250               C                      y = 0.1894x − 5.420          0.999       125--1000                            8.654            28.847
  phellandrene           15              3.57                  210                           C                 y = 8.783x − 145.3     0.998                        125--1000   0.562                                1.874            
  sabinene               16              3.45                  220                           C                 y = 18.14x − 1004      0.998                        125--1000   0.094                                0.314            
  γ-terpinene            17              3.28                  235                           C                 y = 0.4886x − 23.02    0.999                        125--1000   17.577                               58.590           
  terpinolene            18              4.83                  220                           C                 y = 26.52x + 876.8     0.999                        125--1000   0.241                                0.804            
  Organic acids          citric acid     19                    5.30                          214               D                      y = 1.0603x − 22.092         1.000       167--1000                            18.805           62.682
  malic acid             20              4.03                  214                           D                 y = 1.415x − 80.254    0.996                        167--1000   15.721                               52.404           
  oxalic acid            21              7.85                  214                           D                 y = 6.4502x + 6.1503   0.998                        167--1000   0.550                                1.835            
  quinic acid            22              3.21                  214                           D                 y = 0.8087x − 38.021   0.998                        167--1000   26.106                               87.021           
  succinic acid          23              3.46                  214                           D                 y = 0.9236x − 8.0823   0.995                        167--1000   7.135                                23.783           
  tartaric acid          24              5.69                  214                           D                 y = 1.8427x + 15.796   1.000                        167--1000   8.520                                28.401           
  Vitamins               ascorbic acid   25                    4.14                          261               E                      y = 42.71x + 27.969          0.999       100--1000                            0.836            2.786
  dehydroascorbic acid   26              3.41                  348                           E                 y = 4.1628x + 140.01   0.999                        30--300     1.095                                3.649            

According to "multi-marker approach" \[[@B47-pharmaceuticals-09-00007]\], total bioactive compound content (TBCC) was determined as the sum of the most important classes of bioactive compounds present in the samples. Bioactive markers were selected comparing bud-preparation health-promoting properties and the most important compounds in literature with an important role in the positive effects on human organism ([Figure 7](#pharmaceuticals-09-00007-f007){ref-type="fig"}). Four polyphenolic classes were considered: benzoic acids (ellagic and gallic acids), catechins (catechin and epicatechin), cinnamic acids (caffeic, chlorogenic, coumaric, and ferulic acids), and flavonols (hyperoside, isoquercitrin, quercetin, quercitrin, and rutin). Monoterpenes (limonene, phellandrene, sabinene, γ-terpinene, terpinolene), organic acids (citric, malic, oxalic, quinic, succinic, and tartaric acids) and vitamin C (ascorbic and dehydroascorbic acids) were also considered to obtain a complete analytical fingerprint. All results were expressed as mg per 100 g of fresh weight (FW).

3.6. Statistical Analysis {#sec3dot6-pharmaceuticals-09-00007}
-------------------------

Results were subjected to analysis of variance (ANOVA) test for mean comparison (IBM SPSS Statistics, v. 22.0, New York, NY, USA) and HSD Tukey multiple range test (*p* \< 0.05).

![Chemical structures of the main selected biomarkers.](pharmaceuticals-09-00007-g007){#pharmaceuticals-09-00007-f007}

4. Conclusions {#sec4-pharmaceuticals-09-00007}
==============

In this study, *Ribes* and *Rubus* spp. were identified as new sources of natural antioxidants and other health-promoting compounds for use in herbal products. In particular, the results demonstrated that these bud-preparations represent a rich source of polyphenolic (catechins and flavonols) and terpenic compounds and indicated that secondary plant metabolite concentration in bud preparations is highly dependent on harvesting time and plant genotype. For this reason, the concentrations of main bioactive compounds in buds, and consequently in bud-preparations, can be opportunely defined on the basis of chemical-pharmaceutical, agricultural and environmental knowledge. The differences in the phytocomplex chemical composition of blackcurrant and blackberry justify the different medical uses of these preparations; in blackcurrant bud-extracts the most important class was organic acids (50.98%) followed by monoterpenes (14.05%), while in blackberry preparations the main bioactive classes were catechins (50.06%) and organic acids (27.34%).

The HPLC methods used in this study are simple, sensitive and reliable, and could be used for the quality evaluation and control of bud-extracts and natural medicines. The results of this research show that the assessment of chemical composition of the plant-derived products could help in find out new sources of natural antioxidants and other health-promoting compounds which could be used as natural medicines, food additives, functional foods and botanical ingredients in order to develop a new generation of standardized and effect-optimized preparations with high values of quality and safety.

Chemical, genetic and environmental knowledge could be a useful tool for obtaining label certifications for the valorization of specific genotypes, with high clinical and pharmaceutical value: chromatographic fingerprinting could be an effective tool for herbal product characterization and authentication, natural preparation quality control (against contamination and adulteration), bioactivity evaluation of bud preparations, and standardization of all the supply chain steps.
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